Global Epifluidic Diagnostics Technology Advancements and Growth Opportunities

Conventional diagnostics are performed in centralized laboratories involving painful sample collection, time-consuming and expensive logistics and long turnaround. Furthermore, due to the delay in the turnaround, the results indicate the health status of an individual several hours ago. 
Epifluidic diagnostics is an emerging class of wearable diagnostics that enable sweat or interstitial fluid analysis through skin-interfaced microfluidic systems. These body-worn skin-conformable and flexible miniature devices allow painless and continuous sampling of the alternate biofluids for long term and enables real-time and continuous monitoring of diagnostic targets for precise health management.
Sweat-based epifluidic diagnostics are predominantly utilized for hydration management and substance use detection, and interstitial fluid-epifluidic diagnostics are employed for metabolite measurement. Key players are actively expanding interstitial fluid-based epifluidic diagnostics for more clinical uses, such as therapeutic drug monitoring, cardiovascular disease monitoring and sepsis detection. Competitors are competing to provide critical applications, real-time insights, higher accuracy and enhanced user convenience.
Academic research groups have found evidences that sweat and interstitial fluid-based diagnostics can be used for a multitude of diverse applications, ranging from viral infection detection, cystic fibrosis diagnosis, urea monitoring to Parkinson's disease management. Therefore, with several sectors of impact, epifluidic diagnostics has a high market potential in the coming years.
Key players are integrating epifluidic diagnostic devices with advanced information and communication technologies, such as AI/ML algorithms. Therefore, it provides a growth opportunity for AI developers. The continuous health data from epifluidic diagnostic devices will also be valuable for digital twin technology developers.
The epifluidic diagnostic technologies, the benefits and their segments are detailed in the report. The drivers and restraints for the growth of the epifluidic diagnostics industry are explored. The participants in the sweat-based epifluidic diagnostics and interstitial fluid-based epifluidic diagnostics segments, the technologies they employ, their target applications and commercial readiness levels are discussed. The new applications emerging from the academic ecosystem have been explored in the report. The regional trends and development status of the epifluidic diagnostics segments for various applications, the funding, mergers and acquisitions (M&A) and the patent filing trend in the epifluidic diagnostics industry have been analyzed in detail. The growth opportunities for the epifluidic diagnostics industry have also been identified.